Follow The Filings

BJDX Bluejay Diagnostics

Bluejay Diagnostics earnings company data as of 4:00 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by BJDX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BJDX insider trades
  • $222K bought by 6 insiders
  • $49K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Hrt Financial LP 10% owner
    Buy
    $97K 64,047 shares at $1.51 +102% to stake
    Traded Jul 9 Filed Jul 13
  2. Hrt Financial LP 10% owner
    Sale
    $49K 34,938 shares at $1.40 28% of stake
    Traded Jul 10 Filed Jul 13
  3. Douglas Clark Wurth Director
    Buy
    $25K 12,500 shares at $2.00 +11574% to stake
    Traded Mar 14 Filed May 18

Also filed in the last 12 months, not counted as buying or selling: 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01
8-K 7.01,9.01
8-K 1.01,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
8-K 7.01,9.01
10-Q QUARTERLY REPORT
8-K 7.01,9.01
424B3 PROSPECTUS
8-K 5.02,5.07,9.01
8-K 1.01,3.02,8.01,9.01
SCHEDULE 13G —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
8-K 1.01,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q QUARTERLY REPORT
DEF 14A PROXY STATEMENT
8-K 7.01,9.01
8-K 1.01,3.02,9.01
8-K 7.01,9.01
8-K 7.01,9.01
SCHEDULE 13D —
SCHEDULE 13D —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.